LCTX - Lineage Cell Therapeutics Inc
Close
0.8839
0.007 0.803%
Share volume: 442,000
Last Updated: Fri 30 Aug 2024 10:30:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.88
0.01
0.81%
Summary score
9%
Profitability
0%
Dept financing
9%
Liquidity
56%
Performance
6%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-8.06%
Return on assets
-5.99%
Return on sales
-804.59%
Return on invested capital
-22.29%
Total debt ratio
27.68%
Debt ratio change over timeo
-2.73%
Current Ratio
4.58%
Quick Ratio
4.58%
Cash Position Ratio
4.13%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-8.55%
Return on assets
-5.81%
Return on sales
-364.97%
Return on invested capital
-12.81%
Total debt ratio
35.31%
Debt ratio change over timeo
-3.81%
Current Ratio
2.65%
Quick Ratio
2.65%
Cash Position Ratio
2.51%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-9.04%
Return on assets
-6.14%
Return on sales
-461.29%
Return on invested capital
-14.26%
Total debt ratio
33.26%
Debt ratio change over time
-4.11%
Current Ratio
2.71%
Quick Ratio
2.71%
Cash Position Ratio
2.58%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-68.74%
Return on assets
-65.75%
Return on sales
5721.55%
Return on invested capital
-37.73%
Total debt ratio
-273.17%
Debt ratio change over time
-2.73%
Current Ratio
-43.15%
Quick Ratio
-43.15%
Cash Position Ratio
-40.05%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | LCTX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -8.06% | 13.79% | 34.47% | 7.43% |
| Return on assets | -5.99% | 2.76% | 3.15% | 5.62% |
| Return on sales | -804.59% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -22.29% | 2.36% | 5.39% | 19.77% |
| Profitability | 0% | 43% | 66% | 80% |
| Total debt ratio | 27.68% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -2.73% | 308.97% | -6.99% | 1.18% |
| Dept financing | 8% | 50% | 25% | 7% |
| Current Ratio | 2.65% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 2.65% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 2.51% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 11% | 25% | 57% |
| Short-term ratios | LCTX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -8.55% | 13.77% | 13.25% | 3.8% |
| Return on assets | -5.81% | 2.43% | 1.89% | 3.09% |
| Return on sales | -364.97% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -12.81% | 2.14% | 3.39% | 9.18% |
| Profitability | 0% | 71% | 68% | 82% |
| Total debt ratio | 35.31% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -3.81% | 46.38% | -72.08% | 1.51% |
| Dept financing | 9% | 50% | 25% | 7% |
| Current Ratio | 2.65% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 2.65% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 2.51% | 0.36% | 1.28% | 2.93% |
| Liquididy | 48% | 12% | 31% | 75% |